Author Archives: Admin

Kraig Biocraft Laboratories subsidiary Prodigy Textiles signs agreements for mulberry production

ANN ARBOR, Mich., – July 12, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that its subsidiary Prodigy Textiles has signed three agreements with local farming cooperatives in Quang Nam province, Vietnam.  Under these agreements the farmers will produce the mulberry necessary to support the Company’s recombinant spider silk production. 

This collaboration with local farmers is a key element of Kraig Labs commercialization strategy, integrating advancements in high tech agriculture and a diverse supply base with the Company’s ground breaking spider silk production technology.

 “The strength of our approach in creating cost effective and commerciality scalable spider silk has always been based on the use of the existing silk infrastructure,” said Jon Rice, COO.  “Today’s announcement, that we are developing collaborative relationships with these farming cooperatives, is a perfect example of that strategy put into action.  These efforts will provide us with sufficient mulberry to meet our production expansion plans for the next several years.  In the coming months we expect to expand this model of collaboration by incorporating efforts with downstream processors such as reeling and thread finishing.” 

Prodigy Textiles Co. Ltd., signed three memorandums of understanding with independent farming cooperatives at a signing ceremony held at its recently announced new facility in Quang Nam province. 

The Company wishes to offer special thanks to its team of consultants who have put in considerable effort to assist us on this endeavor.  Leading this project was Mr. Kenneth Le, whose dedication, resourcefulness, and business acumen has been instrumental in our ability to conduct business on the other side of the globe.  Mr. Le has played a critical role in supporting scaling up the Company’s spider silk technology beyond the laboratory and with eyes towards the global textile markets.

“Mr. Le has demonstrated an incredible dedication to advancing this technology,” said CEO and Founder Kim Thompson.  “He has been generous with his time while proving unmatched knowledge of international business and an ability to conduct business in Southeast Asia.  Beyond the Company’s appreciation, I would like to personally thank Ken for his sage advice, his honesty, and his guidance throughout this process.  Together, we continue to break new ground in the commercialization of spider silk.”

To view the most recent edition of Kraig’s Spider Sense newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories celebrates the opening of Prodigy Textiles Co. Ltd., facility in Quang Nam, Vietnam

ANN ARBOR, Mich., – July 10, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces that, during its trip to Vietnam last week, the Company celebrated the grand opening of Prodigy Textiles new facility in Quang Nam province.  This facility will have the capacity, utilities, and security to support the planned capacity growth in Vietnam through the first phase of operations and will be the launch pad for future expansion on a pre-designated 50 hectare parcel of land located nearby.

Working in partnership with its consultants in Vietnam, the Company reviewed numerous buildings and locations throughout the province.  The Company ultimately selecting this facility due to its proximity to mulberry production, building layout, condition, utilities, and its proximity to shipping ports and the Company’s planned 50 hectare future campus.

The opening celebration was attended by officials from the province and local district, as well as leaders from the farming cooperatives that will provide mulberry and senior banking officials.

“Having now seen the new facility first hand I am confident that we will soon have a thriving operation up and running,” said Jon Rice, COO.  “We are now in the process of getting the final building updates outlined and completed so that it will be ready to receive the first shipment of our silkworms.  Our team in Vietnam continues to put in an incredible amount of effort to bring this ground breaking project to reality.”

To view the most recent edition of Kraig’s Spider Sense newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories management travels to Vietnam to oversee the opening of its spider silk production subsidiary, Prodigy Textiles Co. Ltd.,

ANN ARBOR, Mich., – July 3, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that Jon Rice, the Company’s COO, is in Vietnam this week reviewing the new facility, interviewing potential hires, and meeting with local officials, as the next phase in launching operations at its newly formed production subsidiary, Prodigy Textiles Co. Ltd. 

This trip marks the first time that Company management will be on the ground in Vietnam, since receiving its investment and enterprise registration certificates, the essential business licenses the Company had worked diligently to secure.  Mr. Rice will remain in Vietnam through the end of the week, ensuring that the factory is on track to receive its first delivery of its proprietary hybrid silkworms.

“I am excited to see the new facility first hand and to review the progress getting the building ready to receive our hybrid silkworms,” said Rice.  “Our consultants on the ground have been doing an excellent job of keeping this project moving forward.  This will be a busy week of meetings, as we coordinate with contractors, officials, and potential new employees, as we work to get Prodigy Textiles up and running.”

The Company’s research team continues to prepare silkworm’s eggs for shipment, from its Michigan based R&D headquarters, and remains on track to ship materials, as soon as the new facility in Vietnam is ready.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories works with local cooperative to expand Mulberry production in Quang Nam, Vietnam

Plans to add nearly 2,500 acres of mulberry to support commercialization scale of up of the Company’s recombinant spider silk technology

ANN ARBOR, Mich., – June 26, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that the Company’s representatives in Quang Nam province, Vietnam are working, in collaboration with a local cooperative, to expand mulberry production.   This effort is a major element of the Company’s production expansion plans and marks a significant increase in capacity. 

News of this collaboration was recently published in a leading Vietnamese digital media outlet, which highlights the efforts to focus on high technology agriculture and re-energize the Vietnamese share of the multi-billion dollar sericulture industry.  Expanding mulberry production in Quang Nam, by nearly 2,500 acres, is a powerful step to increasing total silk production and a key component of the Company’s plan to bring its spider silk technology to market.

“Collaboration with local farmers and workers, leveraging their expertise and knowledge, is core to our production scale up efforts,” said Jon Rice COO.  “This effort highlights the complementary efforts that we are taking, in combination with the leadership in Quang Nam, to restore their traditional sericulture industry, by blending in new high technology agriculture. This continued collaboration will play a key part in the exciting growth potential we’re seeing with our expansion in Vietnam and the market for affordable spider silk materials.”

Original Source Article

http://thoibaokinhdoanh.vn/hop-tac-xa/quang-nam-htx-lien-ket-voi-cong-ty-my-dau-tu-nganh-dau-tam-1048434.html

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories produces first roll of pure Dragon Silk fabric for U.S. Army

ANN ARBOR, Mich., – June 21, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that it has just finished the production of its first roll of pure Dragon Silk fabric, marking the first time that the Company’s proprietary recombinant spider silk fibers were used to create a 100% pure woven silk fabric.

The Company is now preparing to assemble the Dragon Silk material into finalized ballistic shoot packs, per the U.S. Army specifications.  This materials is destined for ballistic performance testing, under the Company’s contract with the U.S. Army, to evaluate its potential for protective apparel applications.

“Dragon Silk, which started as a simple idea in the lab for a better performing silk, is now on the verge of demonstrating its capability to provide lifesaving performance blended with high flexibility and user comfort,” said Jon Rice COO.  “What a proud moment for the Company and all of our employees, as we prepare to process this first roll of Dragon Silk fabric into test samples for the U.S. Army and to assess its ability to assist in protecting the brave men and women of our armed forces, who dedicate themselves to protecting all of us.”

The Company previously developed sample products, in pure and blended knit configurations using its Monster Silk materials, including shirts and gloves.  Today’s announcement marks the first time the Company’s newer and stronger Dragon Silk will be transitioned into an end product.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories deploys new Spider Silk DNA synthesis methodology

More than 2,500 test microinjections completed with expanded lab staff to boost throughput

ANN ARBOR, Mich., – June 12, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that the Company has completed more than 2,500 microinjections using the recently announced new spider silk DNA synthesis methodology.  This new method allows for faster creation of larger and more complex spider silk proteins.  Larger and more complex proteins are believed to produce improved silk strength, toughness, and elasticity.  These improved recombinant spider silk fibers will allow the Company to target an expanded set of end market applications.

To support this expanded research and development capability, the Company added two laboratory staff for increased testing throughput.  The additional lab staff members have been trained and have conducted the majority of the microinjection effort.

By implementing this new validated protocol and completing these initial microinjections, the Company is looking forward to creating new transgenics, at Kraig Labs’ U.S. R&D headquarters, with an abridged development cycle and enhanced materials performance.  The transgenics created using the new protocols are expected to be transitioned into Prodigy Textiles’, the Company’s recently announced Vietnamese subsidiary, commercial production process.  

“Thanks to our lab and production teams’ considerable collaborative effort, this new methodology has already demonstrated the potential to significantly reduce our development timelines. To see it put into practice so quickly and to have already completed the first 2,500 test microinjections is very impressive,” said Jon Rice, COO.  “I look forward to seeing this capability enable the next generation of recombinant spider silk fibers.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories develops new breakthrough Spider Silk DNA Synthesis Protocols accelerating time to market for new products

Kraig Labs’ R&D team raises the bar in transgenic research

ANN ARBOR, Mich., – May 23, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its R&D team has achieved a major breakthrough in the construction of DNA encoding for spider silk proteins. 

With this new capability the Company believes that it should be able to reduce the customization timeframe, for new spider silk technologies, by several months.

The new protocols were developed after Kraig Labs reached out to leading DNA synthesis facilities, which all stated that construction of the desired sequences would be practically impossible, due to the unique structure of spider silk proteins.  Refusing to accept that answer, Kraig’s research team then took on the task directly. 

Using a combination of distinct approaches, Kraig Labs successfully synthesized the highly complex set of spider silk protein construct designs.  This new approach should accelerate the pace of its research and production rollout efforts, as well as reduce costs to develop new transgenics for new potential markets and applications. 

The newly designed protein constructs are currently being prepared for incorporation into the Company’s spider silk platform technology.  Due to their construction, these new designs may have the potential to produce new silk fibers with even greater strength and flexibility than the Company’s current generation of recombinant spider silk. 

“Today’s announcement is another in a long history of Kraig Labs proving the impossible, possible,” said Jon Rice, COO.  “From our first transgenic silkworms, to the creation of Monster Silk and then Dragon Silk, to obtaining approvals for international expansion, the Company has proven, time and time again, that we have the tenacity to reimagine what is possible. These new constructs and the ability to rapidly adapt them could open new and wider applications in military and high performance technical textile markets.  Today we celebrate yet another example of how the Company is changing the rules in biotech development.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories takes next steps in Prodigy Textiles’ Spider Silk Commercialization program

Increased transgenic egg production and staffing of new operations among its New Vietnamese Subsidiary’s next steps

ANN ARBOR, Mich., – May 14, 2018 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers provides an update on progress towards the commercialization of spider silk technology following last week’s announcement of the formation of its Vietnamese subsidiary, Prodigy Textiles Co,. Ltd (“Prodigy”).  The Company views Prodigy as its main production arm for spider silk technologies.

The Company is gearing up production of its proprietary spider silk silkworm eggs in preparation for shipment to Prodigy.  These Silkworms are slated to be the first transgenics produced at Prodigy.

Kraig Labs has identified a facility, in Quang Nam province, with the capacity to support operations and is working with local experts to update and buildout the facility to meet production specifications.    

To bring Prodigy production operations online, Kraig Labs has accelerated Prodigy’s staffing and hiring plans.  Key technical and administration positions within Prodigy have been identified and the Company is working with its consultants in Vietnam to fill these positions. 

Company management is now preparing to travel to Vietnam to oversee Prodigy’s launch, where they will also be oversee hiring core staff, the transfer of the Company’s spider silk silkworm technology, and the beginning of operations. 

“Momentum at Prodigy is growing and we’re focused on the exciting milestones ahead,” said Jon Rice, COO.  “We are busy preparing silkworm eggs for shipment and putting the team in place at Prodigy to hit the ground running.  We are now taking concrete steps to build on all the work we’ve done in Vietnam and to convert that into a thriving operation for spider silk production.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories Granted Long Sought License for Business Operations in Vietnam; Prepares for Grand Opening

Issuance of License seen as the most significant commercial event in the biotechnology Company’s development of spider silk based materials

ANN ARBOR, Mich., – May 1, 2018 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, is very happy to announce today the positive result of its five years of working with the Vietnamese government at both the central and provincial levels: The Company has been issued its long awaited Enterprise Registration Certificate (ERC) required to begin its operations in Vietnam.

“These licenses to operate in a traditional silk producing region are the most substantial milestones for Kraig Labs commercial development since the creation of our first spider silk transgenics,” said Kraig Labs Founder and CEO, Kim Thompson. “Our teams in the U.S.A. and in Vietnam have been working closely with officials in Quang Nam province and with central government ministries to bring this long standing vision to reality.”

The Company’s advanced silk production platform was designed specifically to fit within and utilize existing silk industry infrastructure. The Company’s systems were designed that way in order to provide what the Company believes to be a significant and nearly insurmountable competitive advantage. “Our work to obtain these approvals has been driven by our goal of producing recombinant spider silk on a large scale, which can only be achieved by harnessing the opportunities presented by existing large scale silk production infrastructure,” stated Thompson.

 

The Company has already proven through its contract with the U.S. Army that its spider silk technology can be scaled quickly and efficiently, moving from the laboratories of the University of Notre Dame and into its own research and production facilities. We are now on a path to scale our product to much greater levels, by harnessing existing silk production infrastructure with the capacity to match the demand for our spider silk materials.

 

“Today’s announcement is more than just a major milestone for the Company, it’s a revolutionary step in the commercialization of spider silk,” said Jon Rice, Kraig Labs’ COO. “More than five years of hard work, meetings, and extensive legal and regulatory paperwork, have gone into securing these approvals and licenses. We now stand ready to change an entire industry.”

“This is a historic moment for Kraig Labs and for all of our shareholders who have taken part in this journey with us. Our shareholders know how much time, effort and resources have been expended to reach this goal and for the Company to walk through this exciting threshold,” Thompson concluded.

 

Today’s announcement follows closely on the heels of last week’s announcement of the formation of the Company’s Vietnamese subsidiary Prodigy Textiles Co., Ltd., and the receipt of that subsidiary’s Investment Registration Certificate (IRC). Having been issued both its IRC and with today’s announcement, its Enterprise Registration Certificate (ERC), Prodigy Textiles Co., Ltd. is preparing to begin operation. The issuance of these critical licenses mark a major milestone for Kraig Biocraft Laboratories and the commercialization of spider silk.

 

Kraig considers its new wholly owned subsidiary, Prodigy Textiles Co., Ltd., to be its spider silk production arm. Vietnam has been the focus of the Company’s efforts to launch commercial scale production of recombinant spider silk, due to the country’s existing silk production infrastructure. Kraig estimates that it can produce its recombinant spider silk at prices similar to mundane silk, giving the Company a tremendous competitive advantage.

 

The Company is now preparing for the grand opening of its subsidiary operations in Quang Nam province, Vietnam. Management is preparing to hire staff for the new facilities and is prepping the first allotment of transgenic silkworms to ship from its U.S. research headquarters.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implicatio

ns for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include 

descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Announces Registration of New Vietnamese Subsidiary, Prodigy Textiles Co. Ltd

New subsidiary created as Company’s production arm for large scale Spider Silk production

ANN ARBOR, Mich., – April 24, 2018 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has received approval for the establishment of its new Vietnamese subsidiary, Prodigy Textiles Co. Ltd.  The Company is happy to announce it has received, from Vietnam, its official investment registration certificate for the new subsidiary.  The establishment of the Company’s first subsidiary is seen by management as a major milestone toward its long term goal of establishing large scale spider silk production. 

Vietnam has been the focus of the Company’s efforts to launch commercial scale production of recombinant spider silk, due to the country’s existing silk production infrastructure.  The Company’s advanced silk production platform was designed specifically to fit within and utilize existing silk industry infrastructure.  The Company’s systems were designed that way in order to provide what its founder and CEO, Kim Thompson, believes to be a significant and nearly insurmountable competitive advantage.

While the establishment of Prodigy Textiles Co. Ltd. is viewed by the Company as a major milestone toward commercialization and large scale production, establishing production in Vietnam requires a separate government issued enterprise registration certificate. 

“What a great moment for Kraig Labs and the entire Spider Silk industry.  We anticipate that our new subsidiary in Vietnam will open the doors and pave the way for spider silk production and our commercialization efforts,” said Thompson.  “I want to thank our COO, Jon Rice, and our exceptional team of professional consultants who have worked tirelessly to make the founding of this production arm of our Company a reality.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

 

This entry was posted on by .